Characteristics of Subjects With Overweight or Obesity at the Onset of Hypertension
1 other identifier
observational
100
1 country
1
Brief Summary
The study aims to investigate the characteristics of subjects with hypertension at onset among a cohort of apparently healthy subjects, with overweight or obesity (BMI ≥ 25 Kg / m2), and free of any drug treatment at the baseline. The evaluation includes anthropometric (weight, height, BMI, waist circumference), haematochemical (hormones, metabolic and routine) parameters and the screening for hypertension with ABPM. The diagnosis of hypertension is made in accordance with the 2017 guidelines of the American College of Cardiology / American Heart Association ACC / AHA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2019
CompletedFirst Posted
Study publicly available on registry
September 18, 2019
CompletedStudy Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedSeptember 18, 2019
September 1, 2019
1 year
August 27, 2019
September 17, 2019
Conditions
Outcome Measures
Primary Outcomes (12)
Insulin
Insulin (mIU/L) concentration in serum
At baseline
Potassium
Potassium (mmol/L) concentration in serum
At baseline
Sodium
Sodium (mEq/L) concentration in serum
At baseline
eGFR (estimated glomerular filtration rate)
eGFR (ml/min/1.73 mq)
At baseline
Creatinin
Creatinin (mg/dl) concentration in serum
At baseline
Uric acid
Uric acid (mg/dL) concentration in serum
At baseline
Total cholesterol
Total cholesterol (mg/dL) concentrations in serum
At baseline
Thyroid hormones (FT3, FT4)
FT3 (pg/mL), FT4 (pg/mL) concentration in serum
At baseline
HDL cholesterol
HDL cholesterol (mg/dL) concentrations in serum
At baseline
LDL cholesterol
LDL cholesterol (mg/dL) concentrations in serum
At baseline
Triglycerides
Triglycerides (mg/dL) concentrations in serum
At baseline
TSH
TSH (mU/L) concentration in serum
At baseline
Secondary Outcomes (3)
BMI
At baseline
Height
At baseline
Weight
At baseline
Interventions
Observational and prospective study
Eligibility Criteria
Patients who came to the Outpatient Clinic of Nutrition at the National Institute of Gastroenterology "S. de Bellis," Research Hospital, Castellana Grotte, Italy.
You may qualify if:
- Overweight or obesity (BMI\> 25 Kg/m2)
You may not qualify if:
- Any kind of drug
- Hypertension
- Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.),
- Chronic inflammatory diseases
- Renal failure
- Liver failure
- Angina pectoris
- Myocardial infarction and heart failure
- Genetic heart diseases
- Thrombocytopenias
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Gastroenterology IRCCS S. de Bellis
Castellana Grotte, Bari, 70013, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
August 27, 2019
First Posted
September 18, 2019
Study Start
October 1, 2019
Primary Completion
October 1, 2020
Study Completion
October 1, 2020
Last Updated
September 18, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share